New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, FDA to review broader access to restricted peptides in July BPC 157: Experimental Peptide Creates Risk for Athletes FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog